Commonwealth Equity Services’s Palisade Bio PALI Stock Holding History

Commonwealth Equity Services’s Portfolio PALI Stock Details PALI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$28.9K	Sell	16,500 -150	-0.9%	-$273	﹤0.01%	4236
2025 Q4	$39.1K	Buy	+16,650	New	+$32K	﹤0.01%	4204
2017 Q3	–	Hold	0	–	-$89K	–	2595
2017 Q2	–	Hold	0	–	–	–	2386
2017 Q1	–	Hold	0	–	–	–	2274
2016 Q4	–	Hold	0	–	–	–	2313
2016 Q3	–	Hold	0	–	–	–	2244
2016 Q2	–	Hold	0	–	–	–	2234
2016 Q1	–	Hold	0	–	–	–	2191
2015 Q4	–	Hold	0	–	–	–	2165
2015 Q3	–	Hold	0	–	–	–	2104
2015 Q2	–	Hold	0	–	–	–	2035
2015 Q1	–	Hold	0	–	–	–	2028
2014 Q4	–	Hold	0	–	–	–	1934
2014 Q3	–	Hold	0	–	–	–	1875
2014 Q2	–	Hold	0	–	–	–	1835
2014 Q1	–	Hold	0	–	–	–	1802
2013 Q4	–	Hold	0	–	–	–	1898
2013 Q3	–	Hold	0	–	–	–	1840
2013 Q2	–	Hold	0	–	–	–	1795

Other funds holding PALI

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BGI

B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Commonwealth Equity Services's PALI Position: Q1 2026 in Review

Commonwealth Equity Services reduced its Palisade Bio (PALI) stake by 0.9% in Q1 2026, selling an estimated $273 and leaving 16,500 shares worth $28.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4236.

Commonwealth Equity Services first reported a position in PALI in Q4 2025 and has held it in 2 quarters since. The position peaked at $39.1K in Q4 2025. 96 funds tracked by Wall St. Rank hold PALI as of Q1 2026.

Commonwealth Equity Services held 16,500 shares of Palisade Bio worth $28.9K as of Q1 2026.
Commonwealth Equity Services sold 150 Palisade Bio shares in Q1 2026, an estimated $273.
Palisade Bio made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q1 2026, its #4236 holding.
Commonwealth Equity Services first reported a position in Palisade Bio in Q4 2025 and has held it in 2 quarters since.
Commonwealth Equity Services's Palisade Bio position peaked at $39.1K in Q4 2025.
96 funds tracked by Wall St. Rank held Palisade Bio as of Q1 2026.

Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.